Biologic First Newswire to ... Anti-TNF Therapy PR - One Treat Becomes REMICADE(R)

and Corporation, an Pharma /PRNewswire/ Nov. been now and have HORSHAM, ... treated KENILWORTH, announced one million (infliximab estimated that Schering-Plough patients Mitsubishi 6 Tanabe Pa. Centocor, Inc., Corporation REMICADE(R) today -- N.J., with ...

Read More...